GATC Health company and Manhattan Street Capital are pleased to announce that GATC Health has retained MSC as the platform and service for the companies planned Reg A+ offering.
GATC has retained legal and audit resources to help it prepare for the launch of its planned equity offering.
GATC Health is a leader in the field of Predictive Multiomics™. The company’s powerful technology analyzes biological datasets and unprecedented speed to aid in disease biomarker discovery, clinical trial validation and drug discovery and development. GATC Canna was borne from the vision that medical diagnoses should be based on the most accurate scientific data, made available to doctors and patients via a powerful, easy-to-use portal. Our management and advisory teams are comprised of passionate, experienced professionals in the medical, diagnostic, technology, and finance fields. www.gatchealth.com